ARCHIVES

Upon, Panel Lean To Anecdotal Laetrile Study

This article is from The Cancer Letter archive.

Vol. 03 No. 32 | August 12, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012